Pharma ki
opportunity, Raichur mein.
Raichur sits on NH44, 550km south of Bangalore, with direct connectivity to Belgaum Railway Station and Hyderabad Airport (240km). Deosugur Industrial Area houses USFDA-certified facilities with 500+ production workforce, established supply chains to USA and Europe, and access to national chemical distributors. The cluster produces specialty oncology and non-oncology APIs (Zoledronic Acid, Capecitabine, Bortezomib, Pirfenidone) with production volumes supporting ₹500–1,000 Cr annual market revenue.
Sirf ek product nahi — yeh sab hota hai yahan
- ₹500–1,000 Crore annual revenue, 500+ employees, 1 major production unit
- High
Pharma
First-gen founder with ₹50L–₹2.5Cr capital, 10+ years pharma operations experience, M.Sc/M.Tech in chemistry or pharmacy, 24-month patience for regulatory clearances and first export sale.
Not for: First-time founders without pharma background, anyone with <₹50L capital, founders unable to commit to strict quality compliance and FDA documentation, people uncomfortable with 18-24 month payback periods.
Unit-1 established in Raichur in 1987, USFDA-compliant since inception, exports oncology and non-oncology APIs to USA, Europe, and South Asia; achieved zero 483 observations in 2020 FDA inspection; secured Pirfenidone Tablets ANDA patent in 2020; supplies APIs to 100+ countries with capacity of 500+ employees in Raichur facility alone.
Paise kaise aayenge — revenue roadmap
Sequence matter karta hai. Pehle margin validate karo, tab volume.
Zero se pehli sale tak — actual kaam
Har step realistic hai — Raichur ke liye, as is.
Manufacturer ke liye zaroori info
Infrastructure ready hai — plot lo aur shuru karo
Woh paisa jo tujhe pata nahi tha
Kahan dikhna hai — buyers yahan milte hain
Sourcing aur vendors ki tension mat lo
Raw material suppliers chahiye for starting this business? Instagram pe seedha DM karo → — reply milega.
Seedhe sawaal, seedhe jawab
Pehle product validate karo, phir brand banao
Ye marketing ideas try karna mat bhulna
- LinkedIn B2B outreach — post technical white papers on Capecitabine synthesis optimization, COA comparisons, and USFDA compliance stories; target pharmaceutical procurement heads at Cipla, Aurobindo, Lupin with case studies of zero FDA observations.
- Trade show presence — exhibit at Pharmatech Asia (Mumbai, Feb-Mar), Analytica India (Delhi, Oct), display USFDA certificates, zero 483 observations, and 100-country export network to attract contract manufacturers and EU distributors.
- Pharmaceutical journal advertising + webinar strategy — publish case studies in Indian Journal of Pharmaceutical Sciences or Drug Development & Industrial Pharmacy; host free webinars on API quality benchmarking, regulatory pathways to US/EU markets, targeting R&D heads at medium-sized pharma firms.